Vasopressin versus a combination of vasopressin and tourniquets: a comparison of blood loss in patients undergoing abdominal myomectomies

Authors


  • Presented at the Society of Gynecologic Investigation Annual Meeting, Glasgow, Scotland, March 2009.

  • No financial support or conflicts of interest for any author.

Anupama S.Q. Kathiresan, Department of Obstetrics and Gynecology (D-50), Miller School of Medicine, University of Miami, Jackson Memorial Hospital, 1611 NW 12th Ave, Holtz Building #4070, Miami, FL 33136, USA. Email: anu.kathiresan@gmail.com, akathiresan@med.miami.edu

Abstract

Objective:  To compare blood loss and need for blood transfusions in women who underwent abdominal myomectomies after receiving vasopressin or combined vasopressin and tourniquet.

Methods:  A retrospective chart review was performed reviewing abdominal myomectomies that took place at our institution. Subjects were divided into three groups: no intervention, vasopressin, or combined vasopressin and tourniquet. Blood loss, need for blood transfusion, and drop in hemoglobin and hematocrit were compared across all groups.

Results:  One-hundred and thirty-two subjects were included in the study. No statistically significant difference was found between groups in blood loss, drop in hemoglobin or hematocrit, or blood transfusions.

Conclusion:  Combined vasopressin and tourniquets was not associated with a statistically significant decrease in blood loss or need for blood transfusion.

Ancillary